All In MedTech

Device Trial Radar · NCT04313725

Evaluation of Tangible Boost for Patients With Stevens Johnson Syndrome, Sjogren's Syndrome, and Graft Vs Host Disease

An Evaluation of Tangible Boost Replenishing System for Patients With Stevens Johnson Syndrome, Sjogren's Syndrome, and Graft Versus Host Disease

Last checked: Nov 19, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

28

Actual

Start

Feb 24, 2020

Primary completion

Jun 21, 2023

Study completion Jun 21, 2023

Sponsor

Lead sponsor
Tangible ScienceNot on our public-company list
Sponsor type
Industry
Collaborators
Boston Sight
First posted
Mar 18, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this research is to determine if the Tangible Boost system adequately replenishes the Hydra-PEG coating on the surface of a rigid contact lens. Hydra-PEG is a coating for soft and rigid contact lens, primarily composed of polyethylene glycol-based hydrogel, which is covalently bound to the surface of a contact lens. The Hydra-PEG coating is intended to improve wettability and comfort with contact lenses and is currently FDA approved on a number of contact lenses. For patients with Stevens Johnson Syndrome (SJS) (SS), or Graft versus Host disease (GVHD), diminished efficacy of the Hydra-PEG coating can lead to significant decline in satisfaction with the lenses over time. This is a prospective study to evaluate the efficacy of Tangible Boost, a monthly conditioning solution, to replenish the Hydra-PEG coating on rigid gas permeable contact lenses for patients with SJS, GVHD, and SS. Outcomes from this patient population will be compared to patients with dry eye disease.

Conditions

  • Stevens-Johnson Syndrome
  • Graft Versus Host Disease in Eye
  • Sjogren's Syndrome
  • Dry Eye

Interventions

  • Tangible BoostDevice

    Patients will perform a monthly Tangible Boost treatment on their Hydra-PEG treated contact lenses.

  • PlaceboOther

    Patients will perform a monthly placebo (saline) treatment on their Hydra-PEG treated contact lenses.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Visual AcuityTime frame: 3 months
  2. Visual AcuityTime frame: 6 months
  3. Contact Lens ComfortTime frame: 3 months

5 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Boston Sight

    Needham, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.